The potential of soy isoflavones in the supportive therapy for female hormonal disorders: a perspective in the context of polyendocrine metabolic ovarian syndrome and endometriosis
Human Milk Bank Foundation, Warsaw, Poland
Laboratory of Human Milk and Lactation Research, Department of Medical Biology, Medical University of Warsaw, Warsaw, Poland
Menopause Rev 2026; 25(3)
Data publikacji online: 2026/11/09
- Colombo GE, Salmeri N, Leonardi M. Integrating IVF and surgical management in endometriosis-associated infertility: a review. Adv Ther 2026; 43: 1004-1015.
- Sajjad W, Saddique MN, Shahid F, Ijaz A, Bashir MA, Safiullah M, et al. Efficacy of sequential letrozole and gonadotropin therapy for ovulation induction in women with polycystic ovary syndrome: a systematic review and meta-analysis. Ann Med Surg (Lond) 2025; 88: 672-684.
- Dinsdale NL, Crespi BJ. Endometriosis and polycystic ovary syndrome are diametric disorders. Evol Appl 2021; 14: 1693-1715.
- Crespi B. Variation among human populations in endometriosis and PCOS: a test of the inverse comorbidity model. Evol Med Public Health 2021; 9: 295-310.
- Kirkegaard S, Uldall Torp NM, Andersen S, Andersen SL. Endometriosis, polycystic ovary syndrome, and the thyroid: a review. Endocr Connect 2024; 13: e230431.
- Sulak M, Halici Z. Role of phytoestrogens in endometriosis. J Obstet Gynaecol Res 2025; 51.
- Te Velde E, Burdorf A, Nieschlag E, Eijkemans R, Kremer JAM, Roele- veld N, et al. Is human fecundity declining in Western countries? Hum Reprod 2010; 25: 1348-1353.
- Wood JW. Fecundity and natural fertility in humans. Oxf Rev Reprod Biol 1989; 11: 61-109.
- Practice Committee of American Society for Reproductive Medicine in collaboration with Society for Reproductive Endocrinology and Infertility. Optimizing natural fertility. Fertil Steril 2008; 90.
- American and Gynecologists Committee on Gynecologic Practice and Practice Committee. Female age-related fertility decline. Committee Opinion No. 589. Fertil Steril 2014; 101: 633-634.
- Adebisi OY, Singh M, Tobler KJ. Female infertility. In: StatPearls. (FL): StatPearls Publishing (accessed: 12.04.2026).
- Madjunkov M, Madjunkova S, Librach C. The biology and clinical aspects of female infertility. Syst Biol Reprod Med 2026; 72: 23-54.
- Ombelet W. Global access to infertility care in developing countries: a case of human rights, equity and social justice. Facts Views Obgyn 2011; 3: 257-266.
- Bulun SE. Endometriosis. N Engl J Med 2009; 360: 268-279.
- Swift B, Taneri B, Becker CM, Basarir H, Naci H, Missmer SA, et al. Prevalence, diagnostic delay and economic burden of endometriosis and its impact on quality of life: results from an population. Eur J Public Health 2024; 34: 244-252.
- Yovich JL, , Lingham S, Sillender M, Srinivasan S. Pathogenesis of endometriosis: look no further than John Sampson. Reprod Biomed Online 2020; 40: 7-11.
- Dymanowska I, Frankowska K, Cencelewicz K, Kusaj A, Bździuch P, Stachurski P, et al. Eutopic endometrium immune changes involved in development and progression of endometriosis: a review. Med Sci Monit 2026; 32: e949643.
- Stillman RJ, Miller LC. Diethylstilbestrol exposure in utero and endometriosis in infertile females. Fertil Steril 1984; 41: 369-372.
- Uncu G, Kasapoglu I, Ozerkan K, Seyhan A, Yilmaztepe AO, Ata B. Prospective assessment of the impact of endometriomas and their removal on ovarian reserve and determinants of the rate of decline in ovarian reserve. Hum Reprod 2013; 28: 2140-2145.
- Boroncsok D, Filó A, Török M, Vágó H, Ács N, Sobel G. The role of lifestyle and diet in the treatment of endometriosis: a review. Nutrients 2026; 18: 142.
- Teede HJ, Misso ML, Costello MF, Dokras A, Laven J, Moran L, et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Fertil Steril 2018; 110: 364-379.
- Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004; 19: 41-47.
- Bu Z, Hu L, Su Y, Guo Y, Zhai J, Sun YP. Factors related to early spontaneous miscarriage during IVF/ICSI treatment: an analysis of 21,485 clinical pregnancies. Reprod Biomed Online 2020; 40: 201-206.
- Sanchez N. Women with polycystic ovary syndrome: a marginalized population in the . Health Soc Work 2020; 45: 40-46.
- Sibal R, Keogh M, Latthe P, Idkowiak J. Non-hormonal pharmacological interventions in adolescent polycystic ovary syndrome (PCOS): a systematic review. J Pediatr Adolesc Gynecol 2026; 39: 527-534.
- Russo M, Oliva MM, Nordio M, Porcaro G, Unfer V. Metformin and myo-inositol: a comparative analysis. Gynecol Obstet Invest 2026; 91: 411-423.
- Qin S, Guo S, Tan X, Li K, Huang J. Research progress of gut microbiota and its metabolites in polycystic ovary syndrome. Front Endocrinol () 2025; 16: 1700191.
- Sakai T, Kogiso M. Soy isoflavones and immunity. J Med Invest 2008; 55: 167-173.
- Ørgaard A, Jensen L. The effects of soy isoflavones on obesity. Exp Biol Med () 2008; 233: 1066-1080.
- Thompson LU, Boucher BA, Liu Z, Cotterchio M, Kreiger N. Phytoestrogen content of foods consumed in Canada, including isoflavones, lignans, and coumestan. Nutr Cancer 2006; 54: 184-201.
- Shukla V, Chandra V, Sankhwar P, Popli P, Kaushal JB, Sirohi VK, et al. Phytoestrogen genistein inhibits EGFR/PI3K/NF-B activation and induces apoptosis in human endometrial hyperplasia cells. RSC Adv 2015; 5: 56075-56085.
- Reger MK, Zollinger TW, Liu Z, Jones J, Zhang J. Association between urinary phytoestrogens and C-reactive protein in the continuous National Health and Nutrition Examination Survey. J Am Coll Nutr 2017; 36: 434-441.
- Pugeat M, Nader N, Hogeveen K, Raverot G, Dechaud H, Grenot C. Sex hormone-binding globulin gene expression in the liver: drugs and the metabolic syndrome. Mol Cell Endocrinol 2010; 316: 53-59.
- Adlercreutz H, Höckerstedt K, Bannwart C, Bloigu S, Hämäläinen E, Fotsis T, et al. Effect of dietary components, including lignans and phytoestrogens, on enterohepatic circulation and liver metabolism of estrogens and on sex hormone binding globulin (SHBG). J Steroid Biochem 1987; 27: 1135-1144.
- Wang H, Murphy PA. Isoflavone content in commercial soybean foods. J Agric Food Chem 1994; 42: 1666-1673.
- Bajerska J, Mori M, Toda T, Mizuno N, Skoczek-Rubińska A, Bykowska-Derda A, et al. Equol-producing ability of Polish postmenopausal women and the dietary determinants of S-(-) equol formation. Acta Sci Pol Technol Aliment 2024; 23: 77-86.
- Zhang Y, Lu Y, Ma H, et al. Combined exposure to multiple endocrine disruptors and uterine leiomyomata and endometriosis in US women. Front Endocrinol () 2021; 12: 726876.
- Wang HJ, Murphy PA. Isoflavone composition of American and Japanese soybeans in : effects of variety, crop year, and location. J Agric Food Chem 1994; 42: 1674-1677.
- Bhagwat S, Haytowitz DB. USDA Database for the Isoflavone Content of Selected Foods, Release 2.1 (November 2015). , : Nutrient Data Laboratory, , Agricultural Research Department of Agriculture; 2015.
- Legro RS, , Dunaif A. Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome. Am J Med 2001; 111: 607-613.
- Kim JJ, Choi YM. Dyslipidemia in women with polycystic ovary syndrome. Obstet Gynecol Sci 2013; 56: 137-142.
- Wekker V, van Dammen L, Koning A, , Painter RC, Limpens J, et al. Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis. Hum Reprod Update 2020; 26: 942-960.
- Maranon R, Lima R, Spradley FT, do Carmo JM, Zhang H, Smith AD, et al. Roles for the sympathetic nervous system, renal nerves, and CNS melanocortin-4 receptor in the elevated blood pressure in hyperandrogenemic female rats. Am J Physiol Regul Integr Comp Physiol 2015; 308: R708-R713.
- Wu CC, Schwartzman ML. The role of 20-HETE in androgen-mediated hypertension. Prostaglandins Other Lipid Mediat 2011; 96: 45-53.
- Dalmasso C, R, Patil C, Moulana M, Romero DG, Reckelhoff JF. 20-HETE and CYP4A2 -hydroxylase contribute to the elevated blood pressure in hyperandrogenemic female rats. Am J Physiol Renal Physiol 2016; 311: F71-F77.
- Feng H, Jiang K, Zhang YF, Zhuang J, Ku C, Yang J, et al. Improvement of cardiovascular risk factors by genistein supplementation: a systematic review and meta-analysis in diverse population-based RCTs. J Nutr Metab 2025; 2025: 1827252.
- Bhathena SJ, Velasquez MT. Beneficial role of dietary phytoestrogens in obesity and diabetes. Am J Clin Nutr 2002; 76: 1191-1201.
- Zuo T, Zhu M, Xu W. Roles of oxidative stress in polycystic ovary syndrome and cancers. Oxid Med Cell Longev 2016; 2016: 8589318.
- Haudum C, Lindheim L, Ascani A, Trummer C, Horvath A, Münzker J, et al. Impact of short-term isoflavone intervention in polycystic ovary syndrome (PCOS) patients on microbiota composition and metagenomics. Nutrients 2020; 12: 1622.
- Li N, Wu X, Zhuang W, Xia L, Chen Y, Zhao R, et al. Soy and isoflavone consumption and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomized trials in humans. Mol Nutr Food Res 2020; 64.
- Jayagopal V, Albertazzi P, Kilpatrick ES, Howarth EM, Jennings PE, Hep- burn DA, et al. Beneficial effects of soy phytoestrogen intake in postmenopausal women with type 2 diabetes. Diabetes Care 2002; 25: 1709-1714.
- De Gregorio C, Marini H, Alibrandi A, di Benedetto A, Bitto A, Adamo EB, et al. Genistein supplementation and cardiac function in postmenopausal women with metabolic syndrome: results from a pilot strain-echo study. Nutrients 2017; 9: 584.
- Squadrito F, Marini H, Bitto A, Altavilla D, Polito F, Adamo EB, et al. Genistein in the metabolic syndrome: results of a randomized clinical trial. J Clin Endocrinol Metab 2013; 98: 3366-3374.
- Lu R, Zheng Z, Yin Y, Jiang Z. Effect of genistein on cholesterol metabolism- related genes in HepG2 cell. J Food Sci 2019; 84: 2330-2336.
- Lin AH, Leung GP, Leung SW, Vanhoutte PM, Man RY. Genistein enhances relaxation of the spontaneously hypertensive rat aorta by transactivation of epidermal growth factor receptor following binding to membrane estrogen receptors- and activation of a G protein-coupled, endothelial nitric oxide synthase-dependent pathway. Pharmacol Res 2011; 63: 181-189.
- Rosenfield RL, Ehrmann DA. The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited. Endocr Rev 2016; 37: 467-520.
- Wang Q, Sun Y, Xu Q, Liu W, Wang P, Yao J, et al. Higher dietary inflammation potential and certain dietary patterns are associated with polycystic ovary syndrome risk in : a case-control study. Nutr Res 2022; 100: 1-18.
- Zeber-Lubecka N, Ciebiera M, Hennig EE. Polycystic ovary syndrome and oxidative stress-from bench to bedside. Int J Mol Sci 2023; 24: 14126.
- Liu XX, Li SH, Chen JZ, Sun K, Wang XJ, Wang XG, et al. Effect of soy isoflavones on blood pressure: a meta-analysis of randomized controlled trials. Nutr Metab Cardiovasc Dis 2012; 22: 463-470.
- Hall KD, Ayuketah A, Brychta R, Cai H, Cassimatis T, , et al. Ultra-processed diets cause excess calorie intake and weight gain: an inpatient randomized controlled trial of ad libitum food intake. Cell Metab 2019; 30: 67-77.e3.
- Hwang J, Wang J, Morazzoni P, Hodis HN, Sevanian A. The phytoestrogen equol increases nitric oxide availability by inhibiting superoxide production: an antioxidant mechanism for cell-mediated LDL modification. Free Radic Biol Med 2003; 34: 1271-1282.
- Wiegand H, Wagner AE, Boesch-Saadatmandi C, Kruse HP, Kulling S, Rimbach G. Effect of dietary genistein on phase II and antioxidant enzymes in rat liver. Cancer Genomics Proteomics 2009; 6: 85-92.
- Dereń K, Michońska I, Dymek A, Zielińska M, Łuszczki E. Soy isoflavones and PCOS: role in hormonal and metabolic mechanisms. Appl Sci 2025; 15: 6198.
- Rajan RK, M SS, Balaji B. Soy isoflavones exert beneficial effects on letrozole-induced rat polycystic ovary syndrome (PCOS) model through anti-androgenic mechanism. Pharm Biol 2017; 55: 242-251.
- Jamilian M, Asemi Z. The effects of soy isoflavones on metabolic status of patients with polycystic ovary syndrome. J Clin Endocrinol Metab 2016; 101: 3386-3394.
- Khani B, Mehrabian F, Khalesi E, Eshraghi A. Effect of soy phytoestrogen on metabolic and hormonal disturbance of women with polycystic ovary syndrome. J Res Med Sci 2011; 16: 297-302.
- Romualdi D, Costantini B, Campagna G, Lanzone A, Guido M. Is there a role for soy isoflavones in the therapeutic approach to polycystic ovary syndrome? Results from a pilot study. Fertil Steril 2008; 90: 1826-1833.
- Forouhari SE, Heidari Z, Tavana Z, Salehi M, Sayadi M. The effect of soya on some hormone levels in women with polycystic ovary syndrome (balance diet): a cross over randomized clinical trial. Bull Environ Pharmacol Life Sci 2013; 3: 246-250.
- Liyanage GSG, Inoue R, Fujitani M, Ishijima T, Shibutani T, Abe K, et al. Effects of soy isoflavones, resistant starch and antibiotics on polycystic ovary syndrome (PCOS)-like features in letrozole-treated rats. Nutrients 2021; 13: 3759.
- Ma X, Li X, Ma L, Chen Y, He S. Soy isoflavones alleviate polycystic ovary syndrome in rats by regulating NF-B signaling pathway. Bioengineered 2021; 12: 7215-7223.
- Xiao CW, Carbonel AA, Lima PDA, Hendry A, Tsang BK. Consumption of soya isoflavones improved polycystic ovary syndrome-associated metabolic disorders in a rat model. Br J Nutr 2024; 132: 416-424.
- Song KB, Atkinson C, Frankenfeld CL, Jokela T, Wähälä K, Thomas WK, et al. Prevalence of daidzein-metabolizing phenotypes differs between Caucasian and Korean American women and girls. J Nutr 2006; 136: 1347-1351.
- Setchell KD, Cole SJ. Method of defining equol-producer status and its frequency among vegetarians. J Nutr 2006; 136: 2188-2193.
- RF, Mitwally MF. Use of the aromatase inhibitor letrozole for ovulation induction in women with polycystic ovarian syndrome. Clin Obstet Gynecol 2011; 54: 685-695.
- Alivandi Farkhad S, Khazali H. Therapeutic effects of isoflavone-aglycone fraction from soybean (Glycine max L. Merrill) in rats with estradiol valerate-induced polycystic ovary syndrome as an inflammatory state. Gynecol Endocrinol 2019; 35: 1078-1083.
- Rajaei S, Alihemmati A, Abedelahi A. Antioxidant effect of genistein on ovarian tissue morphology, oxidant and antioxidant activity in rats with induced polycystic ovary syndrome. Int J Reprod Biomed 2019; 17: 11-22.
- Kyama CM, Debrock S, Mwenda JM, D’Hooghe TM. Potential involvement of the immune system in the development of endometriosis. Reprod Biol Endocrinol 2003; 1: 123.
- Huhtinen K, Ståhle M, Perheentupa A, Poutanen M. Estrogen biosynthesis and signaling in endometriosis. Mol Cell Endocrinol 2012; 358: 146-154.
- Zondervan KT, Becker CM, Koga K, et al. Endometriosis. Nat Rev Dis Primers 2018; 4: 9.
- Romano A, Xanthoulea S, Giacomini E, Delvoux B, Alleva E, Vigano P. Endometriotic cell culture contamination and authenticity: a source of bias in <i>in vitro</i> research? Hum Reprod 2020; 35: 364-376.
- Kirichenko TV, Myasoedova VA, Orekhova VA, Ravani AL, Nikitina NA, Grechko AV, et al. Phytoestrogen-rich natural preparation for treatment of climacteric syndrome and atherosclerosis prevention in perimenopausal women. Phytother Res 2017; 31: 1209-1214.
- Tsuchiya M, Miura T, Hanaoka T, Iwasaki M, Sasaki H, Tanaka T, et al. Effect of soy isoflavones on endometriosis: interaction with estrogen receptor 2 gene polymorphism. Epidemiology 2007; 18: 402-408.
- Nagata C, Takatsuka N, Kawakami N, Shimizu H. Soy product intake and premenopausal hysterectomy in a follow-up study of Japanese women. Eur J Clin Nutr 2001; 55: 773-777.
- Mitsunami M, Soria-Contreras DC, Ortiz-Panozo E, Harris HR, Missmer SA, Chavarro JE. Soy consumption and the risk of laparoscopically confirmed endometriosis in a prospective cohort study. Fertil Steril 2025; 124 ( 2): 1061-1070.
- Bulun SE, Fang Z, Imir G, Gurates B, Tamura M, Yilmaz B, et al. Aromatase and endometriosis. Semin Reprod Med 2004; 22: 45-50.
- Chen Y, Chen C, Shi S, Han J, Wang J, Hu J, et al. Endometriotic implants regress in rat models treated with puerarin by decreasing estradiol level. Reprod Sci 2011; 18: 886-891.
- Yavuz E, Oktem M, Esinler I, Toru SA, Zeyneloglu HB. Genistein causes regression of endometriotic implants in the rat model. Fertil Steril 2007; 88: 1129-1134.
- Sutrisno S, Sulistyorini C, Manungkalit EM, Winarsih L, Noorhamdani N, Winarsih S. The effect of genistein on TGF-b signal, dysregulation of apoptosis, cyclooxygenase-2 pathway, and NF-B pathway in mice peritoneum of endometriosis model. Fertil Soc J 2017; 22: 295-299.
- Sutrisno S, Mariyani M, Herawati I, Rinata E, Jehanara J, Yueniwati Y, et al.The effects of genistein as antiinflammatory and antiangiogenesis in primary endometriosis cell culture. Asian Pac J Reprod 2014; 3: 299-304.
- Otun J, Sahebkar A, Östlundh L, Atkin SL, Sathyapalan T. Systematic review and meta-analysis on the effect of soy on thyroid function. Sci Rep 2019; 9: 3964.
- Grace PB, Taylor JI, Low YL, Luben RN, Mulligan AA, Botting NP. Phytoestrogen concentrations in serum and spot urine as biomarkers for dietary phytoestrogen intake and their relation to breast cancer risk in European prospective investigation of cancer and nutrition-Norfolk. Cancer Epidemiol Biomarkers Prev 2004; 13: 698-708.
- Mvondo MA, Ekenfack JD, Minko Essono S, Namekong HS, Awounfack CF, Laschke MW, et al. Soy intake since the prepubertal age may contribute to the pathogenesis of endometriosis in adulthood. J Med Food 2019; 22: 631-638.
- , J, Furne JK, Lohrmann TT, Kerr PS, Levitt MD. Gas production in human ingesting a soybean flour derived from beans naturally low in oligosaccharides. Am J Clin Nutr 1999; 69: 135-139.
- Varney JE, So D, Gibson PR, Rhys-Jones D, Lee YSJ, Fisher J, et al. Clinical trial: effect of a 28-day low FODMAP diet on gastrointestinal symptoms associated with endometriosis (EndoFOD) – a randomised, controlled crossover feeding study. Aliment Pharmacol Ther 2025; 61: 1889-1903.
- Petroski W, Minich DM. Is there such a thing as “anti-nutrients”? A narrative review of perceived problematic plant compounds. Nutrients 2020; 12: 2929.
Copyright: © 2026 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.